Saturday, November 2, 2019
This conference has already taken place.
Description
This continuing medical education activity will address new medication and technology that is being utilized in electrophysiology, heart failure and structural heart disease. Many times these disease states overlap which necessitates knowing what medication and devices are being used and how they will impact their patients health. The benefits and risks of new procedures for cardiovascular diseases will also be addressed including pre-procedural testing, how to determine patients for procedure, and post-procedure care. New pharmacological and device therapies for atrial fibrillation, heart failure and structural heart disease will be included.
For pricing information, see pricing tab below.
Dates and Times
Start: 11/2/2019 12:00 AM
End: 11/2/2019 12:00 AM
Objectives
At the conclusion of this continuing medical education activity participants should be able to:
1. Define ejecting and non-ejecting PVCs;
2. Review impact of non-ejecting PVCs on hemodynamics and cardiac performance;
3. Evaluation and management of pre, intra and post TAVR conduction disorder;
4. Describe therapy for massive pulmonary embolism;
5. Update on new therapies for heart failure and heart transplant;
6. Discuss the value of dedicated heart failure clinic;
7. Update on diagnostic and management of pulmonary hypertension and right heart
failure;
8. Recognition of the clinical presentation and management of spontaneous coronary
artery dissection (SCAD);
9. Discuss new recommendations on oral anticoagulation therapy in patient with atrial
fibrillation and coronary artery disease.
Pricing
| Tier | Price |
|---|---|
| Physicians | $0.00 |
| Nurses | $0.00 |
| Other Health Professionals | $0.00 |
Speakers
Location
The Ohio State University Lima
Reed Hall
4240 Campus Drive
Lima, OH 45804
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 3.50 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.